Building strong and lasting partnership is essential to the success of our business and our customers.  We pursue innovation through both internal R&D and external collaboration.  Partnerships and collaborations are critical to evolving our portfolio and driving our long-term sustainability.

● Out-licensing: we seek partners with global R&D and commercial expertise to help realize the full potential of our innovative assets on a global or regional level.
● In-licensing: we are constantly seeking and evaluating both late-stage clinical assets that may complement our in-house pipelines and first-in-class compounds with breakthrough potential.
● Strategic collaboration: we are open to working with any entities, industrial or academic institutions on any scale. Also, we welcome diversified novel ideas with the potential to help our patients and maximize the power of our portfolio.